Adaptin Bio (APTN) Cash & Equivalents Growth (3y) (2025)
Powered by 
Analysis
Adaptin Bio (APTN) Cash & Equivalents Growth (3y) (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 15.74% |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.80 Bn | 3.50 Bn | 55.72 Mn | -21.61% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -20.41% |
| 5 | uniQure | 3.04 Bn | 3.04 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.64 Bn | 2.64 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -12.18% |
| 9 | Vericel | 1.98 Bn | 1.82 Bn | 56.40 Mn | 42.85% |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | - |